WiseGuyReports.Com Publish a New
Market Research Report On –“Interleukin 15 (IL15) 2016 Global Market
Opportunities and Forecasts to 2021”.
COMPLETE
REPORT DETAILS @
https://www.wiseguyreports.com/reports/589988-interleukin-15-il15-pipeline-review-h1-2016
The, ‘Interleukin 15 (IL15) - Pipeline Review, H1
2016’, provides in depth analysis on Interleukin 15 (IL15) targeted
pipeline therapeutics.
The report provides comprehensive information on the
Interleukin 15 (IL15), targeted therapeutics, complete with analysis by
indications, stage of development, mechanism of action (MoA), route of
administration (RoA) and molecule type. The report also covers the descriptive
pharmacological action of the therapeutics, its complete research and
development history and latest news and press releases. Additionally, the
report provides an overview of key players involved in Interleukin 15 (IL15)
targeted therapeutics development and features dormant and discontinued
projects.
For more information or any query mail at sales@wiseguyreports.com
The report features investigational drugs from
across globe covering over 20 therapy areas and nearly 3,000 indications. The
report is built using data and information sourced from Global Markets Direct’s
proprietary databases, company/university websites, clinical trial registries,
conferences, SEC filings, investor presentations and featured press releases
from company/university sites and industry-specific third party sources. Drug
profiles featured in the report undergoes periodic review following a stringent
set of processes to ensure that all the profiles are updated with the latest
set of information. Additionally, various dynamic tracking processes ensure
that the most recent developments are captured on a real time basis.
The report helps in identifying and tracking
emerging players in the market and their portfolios, enhances decision making
capabilities and helps to create effective counter strategies to gain
competitive advantage.
Note*: Certain sections in the report may be removed
or altered based on the availability and relevance of data.
GET
A SAMPLE REPORT @ https://www.wiseguyreports.com/sample-request/589988-interleukin-15-il15-pipeline-review-h1-2016
Scope
- The report provides
a snapshot of the global therapeutic landscape for Interleukin 15 (IL15)
- The report reviews Interleukin 15 (IL15) targeted therapeutics under development by companies and universities/research institutes based on information derived from company and industry-specific sources
- The report covers pipeline products based on various stages of development ranging from pre-registration till discovery and undisclosed stages
- The report features descriptive drug profiles for the pipeline products which includes, product description, descriptive MoA, R&D brief, licensing and collaboration details & other developmental activities
- The report reviews key players involved in Interleukin 15 (IL15) targeted therapeutics and enlists all their major and minor projects
- The report assesses Interleukin 15 (IL15) targeted therapeutics based on mechanism of action (MoA), route of administration (RoA) and molecule type
- The report summarizes all the dormant and discontinued pipeline projects
- The report reviews latest news and deals related to Interleukin 15 (IL15) targeted therapeutics
- The report reviews Interleukin 15 (IL15) targeted therapeutics under development by companies and universities/research institutes based on information derived from company and industry-specific sources
- The report covers pipeline products based on various stages of development ranging from pre-registration till discovery and undisclosed stages
- The report features descriptive drug profiles for the pipeline products which includes, product description, descriptive MoA, R&D brief, licensing and collaboration details & other developmental activities
- The report reviews key players involved in Interleukin 15 (IL15) targeted therapeutics and enlists all their major and minor projects
- The report assesses Interleukin 15 (IL15) targeted therapeutics based on mechanism of action (MoA), route of administration (RoA) and molecule type
- The report summarizes all the dormant and discontinued pipeline projects
- The report reviews latest news and deals related to Interleukin 15 (IL15) targeted therapeutics
Reasons to buy
- Gain strategically
significant competitor information, analysis, and insights to formulate
effective R&D strategies
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Identify and understand the targeted therapy areas and indications for Interleukin 15 (IL15)
- Identify the use of drugs for target identification and drug repurposing
- Identify potential new clients or partners in the target demographic
- Develop strategic initiatives by understanding the focus areas of leading companies
- Plan mergers and acquisitions effectively by identifying key players and it’s most promising pipeline therapeutics
- Devise corrective measures for pipeline projects by understanding Interleukin 15 (IL15) development landscape
- Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Identify and understand the targeted therapy areas and indications for Interleukin 15 (IL15)
- Identify the use of drugs for target identification and drug repurposing
- Identify potential new clients or partners in the target demographic
- Develop strategic initiatives by understanding the focus areas of leading companies
- Plan mergers and acquisitions effectively by identifying key players and it’s most promising pipeline therapeutics
- Devise corrective measures for pipeline projects by understanding Interleukin 15 (IL15) development landscape
- Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope
Table Of Contents – Key Points
List of
Tables 4
List of Figures 4
Introduction 5
Global Markets Direct Report Coverage 5
Interleukin 15 (IL15) Overview 6
Therapeutics Development 7
Interleukin 15 (IL15) - Products under Development by Stage of Development 7
Interleukin 15 (IL15) - Products under Development by Therapy Area 8
Interleukin 15 (IL15) - Products under Development by Indication 9
Interleukin 15 (IL15) - Pipeline Products Glance 10
Late Stage Products 10
Early Stage Products 11
Interleukin 15 (IL15) - Products under Development by Companies 12
Interleukin 15 (IL15) - Products under Development by Universities/Institutes 14
Interleukin 15 (IL15) - Therapeutics Assessment 16
Assessment by Monotherapy/Combination Products 16
Assessment by Mechanism of Action 17
Assessment by Route of Administration 19
Assessment by Molecule Type 21
Interleukin 15 (IL15) - Companies Involved in Therapeutics Development 23
Amgen Inc. 23
Calypso Biotech SA 24
Digna Biotech, S.L. 25
Interleukin 15 (IL15) - Drug Profiles 26
AM-0015 - Drug Profile 26
Product Description 26
Mechanism Of Action 26
R&D Progress 26
AMG-714 - Drug Profile 27
Product Description 27
Mechanism Of Action 27
R&D Progress 27
BNZ-1321 - Drug Profile 29
Product Description 29
Mechanism Of Action 29
R&D Progress 29
BNZ-1322 - Drug Profile 30
Product Description 30
Mechanism Of Action 30
R&D Progress 30
CALY-002 - Drug Profile 31
Product Description 31
Mechanism Of Action 31
R&D Progress 31
DB-039 - Drug Profile 32
Product Description 32
Mechanism Of Action 32
R&D Progress 32
List of Figures 4
Introduction 5
Global Markets Direct Report Coverage 5
Interleukin 15 (IL15) Overview 6
Therapeutics Development 7
Interleukin 15 (IL15) - Products under Development by Stage of Development 7
Interleukin 15 (IL15) - Products under Development by Therapy Area 8
Interleukin 15 (IL15) - Products under Development by Indication 9
Interleukin 15 (IL15) - Pipeline Products Glance 10
Late Stage Products 10
Early Stage Products 11
Interleukin 15 (IL15) - Products under Development by Companies 12
Interleukin 15 (IL15) - Products under Development by Universities/Institutes 14
Interleukin 15 (IL15) - Therapeutics Assessment 16
Assessment by Monotherapy/Combination Products 16
Assessment by Mechanism of Action 17
Assessment by Route of Administration 19
Assessment by Molecule Type 21
Interleukin 15 (IL15) - Companies Involved in Therapeutics Development 23
Amgen Inc. 23
Calypso Biotech SA 24
Digna Biotech, S.L. 25
Interleukin 15 (IL15) - Drug Profiles 26
AM-0015 - Drug Profile 26
Product Description 26
Mechanism Of Action 26
R&D Progress 26
AMG-714 - Drug Profile 27
Product Description 27
Mechanism Of Action 27
R&D Progress 27
BNZ-1321 - Drug Profile 29
Product Description 29
Mechanism Of Action 29
R&D Progress 29
BNZ-1322 - Drug Profile 30
Product Description 30
Mechanism Of Action 30
R&D Progress 30
CALY-002 - Drug Profile 31
Product Description 31
Mechanism Of Action 31
R&D Progress 31
DB-039 - Drug Profile 32
Product Description 32
Mechanism Of Action 32
R&D Progress 32
Continue……
For more information or any query mail at
sales@wiseguyreports.com
CHECK DISCOUNT ON THIS REPORT @ https://www.wiseguyreports.com/check-discount/589988-interleukin-15-il15-pipeline-review-h1-2016
Contact
Us:
NORAH TRENT
Partner
Relations & Marketing Manager
sales@wiseguyreports.com
www.wiseguyreports.com
Ph:
+1-646-845-9349 (US)
Ph:
+44 208 133 9349 (UK)
No comments:
Post a Comment